Program Details
Information about medical programs provided by each healthcare institution, including treatment details, schedules, etc.,
- medical treatment
- detailed examination (ambulatory)
- second opinion
Biliary Drainage Procedures [Osaka Medical and Pharmaceutical University Hospital]
We provide diagnosis and treatment for pancreatic and biliary diseases using state-of-the-art advanced medical technologies.
Equipped with the latest ERCP and EUS-dedicated endoscopes.
We perform one of the highest numbers of pancreaticobiliary endoscopic examinations and treatments in Japan.
Our expertise in histological diagnosis and drainage procedures for pancreatic and biliary cancers is internationally recognized, and our specialists are frequently invited to conduct live endoscopic demonstrations worldwide.
We also have extensive experience in endoscopic tumor ablation and cholangioscopy-guided lithotripsy.
English-language support is available.
Treatment is performed by placing biliary stents under endoscopic retrograde cholangiopancreatography (ERCP) guidance.
In patients with hilar cholangiocarcinoma, multiple stents are placed to improve obstructive jaundice.
For patients in whom ERCP is technically difficult, endoscopic ultrasound-guided biliary drainage is performed, in which a stent is placed into the bile duct from the stomach or duodenum under EUS guidance.
The number of cases for this procedure is the highest in Japan.
- Program details
- 【Program Introduction Video】
Osaka Medical and Pharmaceutical University（EUS Skyline 2023）
https://www.youtube.com/watch?v=zy3lwcBa3gw
- Providing Medical Institution
-
Osaka Medical and Pharmaceutical University Hospital
〒569-8686Google Map https://hospital.ompu.ac.jp/index.html
2-7 Daigakumachi, Takatsuki City Osaka
- Eligibility Criteria/Exclusions for Treatment
- Medical information in Japanese or English, as well as CT images, are required.
- Remarks
- 【Treatment Schedule】
Day 1 (Admission): Examinations and explanation of the treatment plan
Day 2: Examinations and treatment
Day 3: CT scan and blood tests
Day 4: Observation of the patient's progress, including monitoring for the development of symptoms
Day 5: Start of oral intake
Day 6: Observation of the patient's progress, including monitoring for the development of symptoms
Day 7: Discharge
※Depending on the results of the blood tests and CT scan on Day 3, the hospital stay may be extended.
- Precautions / Contraindications
- None